Prevalence of transthyretin amyloid cardiomyopathy in patients admitted for acute heart failure.

Introduction: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed cause of AHF that benefits from a specific approach. The aim was to determine the prevalence of ATTR-CM among patients hospitalized for AHF.

Methods: A prospective study was conducted on consecutive patients aged 60 or older admitted for acute AHF without cardiogenic shock.

[Clopidogrel versus prasugrel in acute coronary syndrome treated with coronary angioplasty].

Greater antithrombotic potency new antiplatelet agents have been added such as prasugrel (PR) and ticagrelor to the traditional use of clopidogrel (CL) in the treatment of acute coronary syndrome (ACS). This study was aimed at comparing the incidence of long term ischemic and hemorrhagic events in patients treated with CL or PR during hospitalization. Retrospective ACS data base analysis performed by our cardiology service was completed prospectively.

Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best?

Vernakalant is a new, safe and effective drug used intravenously. It has proven to be more rapid in converting recent onset atrial fibrillation (AF) to sinus rhythm compared to placebo, amiodarone, propafenone and flecainide in clinical studies with few patients. At present no study has been conducted comparing these three drugs with a more substantial number of patients.